No weight loss drug should be used during pregnancy
By removing the needle barrier, Novo expands the addressable population to patients who defer or avoid injectable therapy, enabling earlier initiation and potentially more sustained real-world use
Glucagon-like peptide receptor agonist inhibits angiotensin II-induced proliferation and migration in vascular smooth muscle cells and ameliorates phosphate-induced vascular smooth muscle cells calcification
Heat can also affect how certain injectable medications should be stored
[Wadden STEP 3, JAMA 2021] STEP 5 Trial (Nature Medicine 2022) Long-term data: patients maintained an average 15.2% weight loss over 2 years of continuous semaglutide use, with sustained metabolic improvements including reduced HbA1c, blood pressure, and waist circumference
Para el posicionamiento de fuerza y rendimiento, esto suele ser aceptable